Minaris Advanced Therapies

Global cell and gene therapy contract manufacturing and development

Founded 1999 · 1,400 employees · United States · Private

Funding:

Private Equity · 2025

Subsidiaries:

Minaris Regenerative Medicine, WuXi Advanced Therapies, OXGENE